Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.
Pilonis, Nastazja D
The Lancet Gastroenterology and Hepatology
MetadataShow full item record
Di Pietro, M., Modolell, I., O'Donovan, M., Price, C., Pilonis, N. D., Debiram-Beecham, I., & Fitzgerald, R. (2020). Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.. The Lancet Gastroenterology and Hepatology, 5 (9), 805-806. https://doi.org/10.1016/S2468-1253(20)30242-9
During the COVID-19 pandemic, endoscopy services have been severely curtailed—eg, in England, UK, a 30% reduction of diagnostic endoscopies has been reported for the period between January and April, 2020, compared with the same period in 2019, with an estimated 750 oesophagogastric cancers going undiagnosed. A delay in oesophageal cancer diagnosis could adversely affect outcomes, such as has previously been seen with low endoscopy referral rates being linked with poor outcomes from oesophageal cancer.
Embargo Lift Date
External DOI: https://doi.org/10.1016/S2468-1253(20)30242-9
This record's URL: https://www.repository.cam.ac.uk/handle/1810/310111
All rights reserved